Skip to content

Children's Place PLCE Proceeds From Issuance Of Warrants

Proceeds From Issuance Of Warrants at other companies

Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$2.91M
Replimune Group logo
Replimune GroupREPL
$0-100%
Sidus Space, Inc. logo
Sidus Space, Inc.SIDU
$5.63K
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$3.54M
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$5.86M
ALD
Aldel Financial II Inc.ALDF
$100K

Other financials

Income statement

See full
Revenue$215.2M-11.1%
Gross profit$53.4M-24.6%
Operating income-$42.2M-74.9%
Net income-$53.2M-56.3%
EPS (diluted)-$2.40-52.9%

Balance sheet

See full
Cash & equivalents$4.8M-16.0%
Total debt$278.5M-2.7%
Total equity-$107.2M-7,678%
Total assets$729.2M-6.5%

Cash flow

See full
Operating cash flow-$53.8M-25.2%
CapEx$8.0M+135%
Free cash flow-$61.8M-33.3%

Valuation

See full
Market cap$67.82M-36.3%
Enterprise value$341.53M-11.4%
P/S0.1×0.0×

Profitability

See full
Gross margin29.1%-3.0pp
Operating margin-6.4%
Net margin-9.1%-40.6pp
FCF margin-8.6%+68.6pp

Returns & leverage

See full
Return on equity-46.2%-86.9pp
Debt / equity202.3×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Children's Place in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.

The official record: Children's Place’s 10-Q, filed June 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Children's Place's proceeds from issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Children's Place's proceeds from issuance of warrants?
Children's Place (PLCE) reported proceeds from issuance of warrants of $0 in Q1 2026.
How has Children's Place's proceeds from issuance of warrants changed year-over-year?
Children's Place's proceeds from issuance of warrants decreased by 100.0% year-over-year, from $90M to $0.
What does proceeds from issuance of warrants mean?
This measures the cash inflows generated from the sale or issuance of warrants, which grant holders the right to purchase company stock at a specified price. It represents a form of equity financing that can provide immediate liquidity while potentially diluting existing shareholders in the future. Investors monitor this to evaluate the company's reliance on equity-linked instruments for capital raising.